Cargando…

Anti-Cancer Effect of Ginsenoside F(2) against Glioblastoma Multiforme in Xenograft Model in SD Rats

The glioblastoma multiforme (GBM) is the most common malignant brain tumor in adults. Despite combination treatments of radiation and chemotherapy, the survival periods are very short. Therefore, this study was conducted to assess the potential of ginsenoside F(2) (F2) to treat GBM. In in vitro expe...

Descripción completa

Detalles Bibliográficos
Autores principales: Shin, Ji Yon, Lee, Jung Min, Shin, Heon Sub, Park, Sang Yong, Yang, Jung Eun, Cho, Somi Kim, Yi, Tae-Hoo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Society of Ginseng 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3659572/
https://www.ncbi.nlm.nih.gov/pubmed/23717108
http://dx.doi.org/10.5142/jgr.2012.36.1.86
_version_ 1782270464508297216
author Shin, Ji Yon
Lee, Jung Min
Shin, Heon Sub
Park, Sang Yong
Yang, Jung Eun
Cho, Somi Kim
Yi, Tae-Hoo
author_facet Shin, Ji Yon
Lee, Jung Min
Shin, Heon Sub
Park, Sang Yong
Yang, Jung Eun
Cho, Somi Kim
Yi, Tae-Hoo
author_sort Shin, Ji Yon
collection PubMed
description The glioblastoma multiforme (GBM) is the most common malignant brain tumor in adults. Despite combination treatments of radiation and chemotherapy, the survival periods are very short. Therefore, this study was conducted to assess the potential of ginsenoside F(2) (F2) to treat GBM. In in vitro experiments with glioblastoma cells U373MG, F2 showed the cytotoxic effect with IC(50) of 50 μg/mL through apoptosis, confirmed by DNA condensation and fragmentation. The cell population of cell cycle sub-G1 as indicative of apoptosis was also increased. In xenograft model in SD rats, F2 at dosage of 35 mg/kg weight was intravenously injected every two days. This reduced the tumor growth in magnetic resonance imaging images. The immunohistochemistry revealed that the anticancer activity might be mediated through inhibition of proliferation judged by Ki67 and apoptosis induced by activation of caspase-3 and -8. And the lowered expression of CD31 showed the reduction in blood vessel densities. The expression of matrix metalloproteinase-9 for invasion of cancer was also inhibited. The cell populations with cancer stem cell markers of CD133 and nestin were reduced. The results of this study suggested that F2 could be a new potential chemotherapeutic drug for GBM treatment by inhibiting the growth and invasion of cancer.
format Online
Article
Text
id pubmed-3659572
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher The Korean Society of Ginseng
record_format MEDLINE/PubMed
spelling pubmed-36595722013-05-28 Anti-Cancer Effect of Ginsenoside F(2) against Glioblastoma Multiforme in Xenograft Model in SD Rats Shin, Ji Yon Lee, Jung Min Shin, Heon Sub Park, Sang Yong Yang, Jung Eun Cho, Somi Kim Yi, Tae-Hoo J Ginseng Res Articles The glioblastoma multiforme (GBM) is the most common malignant brain tumor in adults. Despite combination treatments of radiation and chemotherapy, the survival periods are very short. Therefore, this study was conducted to assess the potential of ginsenoside F(2) (F2) to treat GBM. In in vitro experiments with glioblastoma cells U373MG, F2 showed the cytotoxic effect with IC(50) of 50 μg/mL through apoptosis, confirmed by DNA condensation and fragmentation. The cell population of cell cycle sub-G1 as indicative of apoptosis was also increased. In xenograft model in SD rats, F2 at dosage of 35 mg/kg weight was intravenously injected every two days. This reduced the tumor growth in magnetic resonance imaging images. The immunohistochemistry revealed that the anticancer activity might be mediated through inhibition of proliferation judged by Ki67 and apoptosis induced by activation of caspase-3 and -8. And the lowered expression of CD31 showed the reduction in blood vessel densities. The expression of matrix metalloproteinase-9 for invasion of cancer was also inhibited. The cell populations with cancer stem cell markers of CD133 and nestin were reduced. The results of this study suggested that F2 could be a new potential chemotherapeutic drug for GBM treatment by inhibiting the growth and invasion of cancer. The Korean Society of Ginseng 2012-01 /pmc/articles/PMC3659572/ /pubmed/23717108 http://dx.doi.org/10.5142/jgr.2012.36.1.86 Text en Copyright ©2012, The Korean Society of Ginseng http://creativecommons.org/licenses/by-nc/3.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Articles
Shin, Ji Yon
Lee, Jung Min
Shin, Heon Sub
Park, Sang Yong
Yang, Jung Eun
Cho, Somi Kim
Yi, Tae-Hoo
Anti-Cancer Effect of Ginsenoside F(2) against Glioblastoma Multiforme in Xenograft Model in SD Rats
title Anti-Cancer Effect of Ginsenoside F(2) against Glioblastoma Multiforme in Xenograft Model in SD Rats
title_full Anti-Cancer Effect of Ginsenoside F(2) against Glioblastoma Multiforme in Xenograft Model in SD Rats
title_fullStr Anti-Cancer Effect of Ginsenoside F(2) against Glioblastoma Multiforme in Xenograft Model in SD Rats
title_full_unstemmed Anti-Cancer Effect of Ginsenoside F(2) against Glioblastoma Multiforme in Xenograft Model in SD Rats
title_short Anti-Cancer Effect of Ginsenoside F(2) against Glioblastoma Multiforme in Xenograft Model in SD Rats
title_sort anti-cancer effect of ginsenoside f(2) against glioblastoma multiforme in xenograft model in sd rats
topic Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3659572/
https://www.ncbi.nlm.nih.gov/pubmed/23717108
http://dx.doi.org/10.5142/jgr.2012.36.1.86
work_keys_str_mv AT shinjiyon anticancereffectofginsenosidef2againstglioblastomamultiformeinxenograftmodelinsdrats
AT leejungmin anticancereffectofginsenosidef2againstglioblastomamultiformeinxenograftmodelinsdrats
AT shinheonsub anticancereffectofginsenosidef2againstglioblastomamultiformeinxenograftmodelinsdrats
AT parksangyong anticancereffectofginsenosidef2againstglioblastomamultiformeinxenograftmodelinsdrats
AT yangjungeun anticancereffectofginsenosidef2againstglioblastomamultiformeinxenograftmodelinsdrats
AT chosomikim anticancereffectofginsenosidef2againstglioblastomamultiformeinxenograftmodelinsdrats
AT yitaehoo anticancereffectofginsenosidef2againstglioblastomamultiformeinxenograftmodelinsdrats